Banco Santander, S.A. Novartis Ag Transaction History

Banco Santander, S.A.

  • $7.96 Billion
  • Q4 2024

A detailed history of Banco Santander, S.A. transactions in Novartis Ag stock. As of the latest transaction made, Banco Santander, S.A. holds 57,809 shares of NVS stock, worth $6.09 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
57,809
Previous 58,599 1.35%
Holding current value
$6.09 Million
Previous $6.74 Million 16.54%
% of portfolio
0.07%
Previous 0.08%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025
SELL
$96.78 - $117.18 $76,456 - $92,572
-790 Reduced 1.35%
57,809 $5.63 Million
Q3 2024

Nov 12, 2024
SELL
$106.13 - $120.89 $129,478 - $147,485
-1,220 Reduced 2.04%
58,599 $6.74 Million
Q2 2024

Jul 29, 2024
SELL
$92.57 - $107.37 $152,740 - $177,160
-1,650 Reduced 2.68%
59,819 $6.37 Million
Q1 2024

May 10, 2024
SELL
$95.27 - $108.47 $588,768 - $670,344
-6,180 Reduced 9.14%
61,469 $5.95 Million
Q4 2023

Feb 09, 2024
SELL
$92.27 - $101.54 $387,534 - $426,468
-4,200 Reduced 5.85%
67,649 $6.83 Million
Q3 2023

Nov 08, 2023
SELL
$94.73 - $105.13 $233,983 - $259,671
-2,470 Reduced 3.32%
71,849 $7.32 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $915,022 - $1.04 Million
-9,890 Reduced 11.74%
74,319 $7.5 Million
Q1 2023

May 10, 2023
SELL
$80.03 - $92.81 $4.48 Million - $5.19 Million
-55,970 Reduced 39.93%
84,209 $7.75 Million
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $2.33 Million - $2.86 Million
-30,900 Reduced 18.06%
140,179 $12.7 Million
Q3 2022

Nov 08, 2022
SELL
$74.61 - $87.26 $13,952 - $16,317
-187 Reduced 0.11%
171,079 $13 Million
Q2 2022

Jul 28, 2022
BUY
$80.52 - $93.75 $2.59 Million - $3.02 Million
32,166 Added 23.12%
171,266 $14.5 Million
Q1 2022

May 09, 2022
SELL
$80.11 - $90.62 $4.55 Million - $5.15 Million
-56,839 Reduced 29.01%
139,100 $12.2 Million
Q4 2021

Feb 09, 2022
BUY
$79.7 - $88.13 $3.01 Million - $3.33 Million
37,814 Added 23.91%
195,939 $17.1 Million
Q3 2021

Nov 08, 2021
SELL
$81.78 - $95.14 $1.09 Million - $1.27 Million
-13,340 Reduced 7.78%
158,125 $12.9 Million
Q2 2021

Jul 29, 2021
BUY
$85.24 - $94.15 $1.38 Million - $1.52 Million
16,190 Added 10.43%
171,465 $15.6 Million
Q1 2021

May 10, 2021
BUY
$83.5 - $98.47 $2.3 Million - $2.71 Million
27,570 Added 21.59%
155,275 $13.3 Million
Q4 2020

Feb 12, 2021
BUY
$78.07 - $94.43 $5.03 Million - $6.09 Million
64,455 Added 101.91%
127,705 $12.1 Million
Q3 2020

Nov 09, 2020
BUY
$82.14 - $91.0 $621,799 - $688,870
7,570 Added 13.6%
63,250 $5.5 Million
Q2 2020

Aug 05, 2020
BUY
$80.93 - $91.1 $1.67 Million - $1.87 Million
20,575 Added 58.61%
55,680 $4.86 Million
Q1 2020

May 11, 2020
BUY
$70.67 - $99.01 $634,263 - $888,614
8,975 Added 34.35%
35,105 $2.89 Million
Q4 2019

Feb 07, 2020
BUY
$84.35 - $95.37 $30,365 - $34,333
360 Added 1.4%
26,130 $2.47 Million
Q3 2019

Nov 06, 2019
SELL
$85.54 - $94.26 $195,031 - $214,912
-2,280 Reduced 8.13%
25,770 $2.25 Million
Q2 2019

Aug 07, 2019
BUY
$75.4 - $92.8 $139,490 - $171,680
1,850 Added 7.06%
28,050 $2.55 Million
Q1 2019

May 13, 2019
SELL
$75.32 - $86.15 $329,148 - $376,475
-4,370 Reduced 14.3%
26,200 $2.49 Million
Q4 2018

Feb 12, 2019
SELL
$73.66 - $82.02 $523,722 - $583,162
-7,110 Reduced 18.87%
30,570 $2.62 Million
Q3 2018

Nov 13, 2018
BUY
$66.94 - $77.43 $302,568 - $349,983
4,520 Added 13.63%
37,680 $3.25 Million
Q2 2018

Aug 14, 2018
BUY
$64.91 - $73.36 $184,344 - $208,342
2,840 Added 9.37%
33,160 $2.51 Million
Q1 2018

May 14, 2018
BUY
$70.39 - $84.15 $2.13 Million - $2.55 Million
30,320 New
30,320 $2.45 Million

Others Institutions Holding NVS

# of Institutions
1,462
Shares Held
132M
Call Options Held
1.33M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $227B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Banco Santander, S.A. Portfolio

Follow Banco Santander, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email